David Keire
Advertisement
David Keire is acting laboratory chief, Branch I, Division of Pharmaceutical Analysis, FDA
Articles by David Keire
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on BioPharm International
1
New Lymphoma Indication for CAR T-Cell Therapy Shapes Pipeline
2
Neurimmune and AstraZeneca Expand Efforts to Accelerate Fibril-Depleting Therapies
3
New Draft Guidance Highlights FDA Push Toward Human-Relevant Safety Models
4
Implementing Automation and Flexible Design for Allogeneic Manufacturing
5
